Intellectus Partners’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

Intellectus Partners’s Portfolio NWBOW Stock Details NWBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,750	Closed	-$2K	–	741
2016 Q4	$2K	Buy	+10,750	New	+$3.26K	﹤0.01%	658

Intellectus Partners's NWBOW Position: Q1 2017 in Review

Intellectus Partners sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q1 2017, closing a stake of 10,750 shares — an estimated $2K sold.

Intellectus Partners first reported a position in NWBOW in Q4 2016 and held it in 1 quarter. The position peaked at $2K in Q4 2016. 0 funds tracked by Wall St. Rank hold NWBOW as of Q1 2017.

Intellectus Partners reported no remaining Northwest Biotherapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Intellectus Partners sold 10,750 Northwest Biotherapeutics, Inc. shares in Q1 2017, an estimated $2K.
Intellectus Partners first reported a position in Northwest Biotherapeutics, Inc. in Q4 2016 and held it in 1 quarter.
Intellectus Partners's Northwest Biotherapeutics, Inc. position peaked at $2K in Q4 2016.
0 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q1 2017.

Based on Intellectus Partners's 13F filing for Q1 2017, filed 8 May 2017.